67 related articles for article (PubMed ID: 19462616)
21. Edging toward new therapeutics with cyclin D1 Egl'ng on cancer.
Dang CV
Cancer Cell; 2009 Nov; 16(5):361-2. PubMed ID: 19878865
[TBL] [Abstract][Full Text] [Related]
22. Circulating hTERT DNA in early breast cancer.
Divella R; Tommasi S; Lacalamita R; Daniele A; Abbate I; Garrisi VM; Savino E; Coviello M; Rubini V; Simone G; Paradiso A; Quaranta M
Anticancer Res; 2009 Jul; 29(7):2845-9. PubMed ID: 19596972
[TBL] [Abstract][Full Text] [Related]
23. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
[TBL] [Abstract][Full Text] [Related]
24. [Breast density: a major parameter to follow during hormone replacement therapy].
Gairard B; Guldenfels C; Haehnel P; Mathelin C
Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
[TBL] [Abstract][Full Text] [Related]
25. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
27. The genomic structure, alternative splicing and immune response of Chlamys farreri thioester-containing protein.
Zhang H; Wang L; Song L; Zhao J; Qiu L; Gao Y; Song X; Li L; Zhang Y; Zhang L
Dev Comp Immunol; 2009 Oct; 33(10):1070-6. PubMed ID: 19467260
[TBL] [Abstract][Full Text] [Related]
28. Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?
Hamilton LJ; Evans AJ; Cornford EJ; Rakha EA; Ellis IO; Foulkes WD
Clin Radiol; 2009 Nov; 64(11):1045-7. PubMed ID: 19822236
[No Abstract] [Full Text] [Related]
29. Novel alpha-fetoprotein-V messenger RNA isoforms in humans.
Tagaya H; Fukasawa H; Shoda T; Hoshi K; Hirata S
Reprod Sci; 2009 Aug; 16(8):794-801. PubMed ID: 19494365
[TBL] [Abstract][Full Text] [Related]
30. The expression and function of IGFBP-3 in normal and malignant breast tissue.
McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
[TBL] [Abstract][Full Text] [Related]
31. [Hereditary breast and ovarian cancer syndrome].
Plevová P; Novotný J; Petráková K; Palácová M; Kalábová R; Schneiderová M; Foretová L
Klin Onkol; 2009; 22 Suppl():S8-11. PubMed ID: 19764385
[No Abstract] [Full Text] [Related]
32. [Breast metastasis--an unusual initial clinical manifestation of primary ovarian cancer].
Meier-Meitinger M; Schulz-Wendtland R; Adamietz B
Rofo; 2009 Nov; 181(11):1082-4. PubMed ID: 19623509
[No Abstract] [Full Text] [Related]
33. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer.
Chen YB; Jiang CT; Zhang GQ; Wang JS; Pang D
J Surg Oncol; 2009 Oct; 100(5):382-6. PubMed ID: 19565630
[TBL] [Abstract][Full Text] [Related]
35. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
[TBL] [Abstract][Full Text] [Related]
36. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
37. Introducing molecular subtyping of breast cancer into the clinic?
Sørlie T
J Clin Oncol; 2009 Mar; 27(8):1153-4. PubMed ID: 19204193
[No Abstract] [Full Text] [Related]
38. "Molecular" is not your traditional lab: where disease management meets acute care.
Carlson MR
MLO Med Lab Obs; 2009 Feb; 41(2):38-41. PubMed ID: 19306675
[No Abstract] [Full Text] [Related]
39. CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors.
Salvador F; Gomis RR
EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29789342
[No Abstract] [Full Text] [Related]
40. IBC's 4th Annual Conference on Molecular Diagnostics. September 13-14, 2005, Convention and Expo Center, Boston, MA, USA.
Jain KK
Expert Rev Mol Diagn; 2005 Nov; 5(6):847-9. PubMed ID: 16255626
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
